Fact-checked by Grok 2 weeks ago

Shivering

Shivering is an involuntary physiological response involving rapid, rhythmic contractions of skeletal muscles that generate heat through inefficient ATP utilization, primarily to maintain core body temperature around 37°C when it drops below the set point. It is triggered mainly by exposure, where peripheral signals from thermoreceptors and excite the shivering center in the dorsomedial while being inhibited by the warmer anterior hypothalamic-preoptic area. Beyond , shivering—often manifesting as —can occur during febrile states due to pyrogenic signals like elevating the body’s temperature set point, or in response to infections (, bacterial, or parasitic), post-anesthesia effects, emotional , or adrenaline surges. Physiologically, it increases metabolic heat production up to five times the basal rate, complementing mechanisms like , but ceases in severe below 29.4°C due to . In clinical contexts, persistent shivering signals underlying issues like infections or , warranting warming interventions for -induced cases or targeted treatments (e.g., antipyretics for fever) to address root causes.

Overview

Definition

Shivering is an involuntary physiological response characterized by rapid, rhythmic contractions and relaxations of skeletal muscles, primarily aimed at generating to maintain . These contractions occur across multiple muscle groups, often involving the limbs, , and , and are triggered by the body's detection of or other thermoregulatory imbalances. Unlike deliberate actions, shivering involves alternating bursts of muscle activity without conscious , distinguishing it as a reflexive rather than a coordinated voluntary movement. The oscillations during shivering typically occur at frequencies of 8-10 Hz, as measured through electromyographic (EMG) analysis. This rhythmic pattern contrasts sharply with sustained voluntary contractions, which lack the oscillatory nature and are initiated by higher cortical centers for purposeful tasks, or with pathological tremors such as those in , which are lower frequency (4-6 Hz) and irregular. Shivering is also distinct from epileptic seizures, which arise from abnormal hypersynchronous neuronal discharges in the , often leading to loss of , tonic-clonic convulsions, or postictal states, whereas shivering remains a coordinated, heat-producing response without neurological disruption. Descriptions of shivering as a thermoregulatory phenomenon first appeared in 19th-century medical literature, particularly in studies of hypothermia and cold exposure, where it was noted as a symptomatic response to environmental chilling. For instance, an 1859 case report detailed a patient exhibiting shivering alongside confusion and poor attention after snowstorm exposure, highlighting its role in early understandings of body temperature regulation. Shivering frequently accompanies chills, serving as the primary muscular component of this broader response; while chills encompass subjective sensations of cold, piloerection (goosebumps), and peripheral vasoconstriction to conserve heat, shivering specifically denotes the oscillatory muscle activity that elevates metabolic rate for warmth production.

Physiological Role

Shivering serves as a key mechanism in shivering thermogenesis, a process that generates heat through the rapid, involuntary contractions of skeletal muscles, primarily via the hydrolysis of ATP to ADP and inorganic phosphate, which dissipates energy as heat rather than mechanical work. This contrasts with non-shivering thermogenesis, which occurs predominantly in brown adipose tissue (BAT) through uncoupled mitochondrial respiration mediated by uncoupling protein 1 (UCP1), allowing for heat production without muscle activity. In mammals, shivering thermogenesis activates when environmental cold challenges core body temperature, elevating the whole-body metabolic rate by 2- to 5-fold above basal levels, depending on the intensity and duration of exposure. The physiological integration of shivering occurs via the hypothalamic thermoregulatory center, particularly the and posterior hypothalamus, which coordinates responses to signals from peripheral thermoreceptors. Shivering emerges as a short-term, high-capacity heat-generating response when BAT-mediated non-shivering proves insufficient to maintain thermal , such as during acute or in adults with limited BAT activity. This hierarchical activation ensures efficient energy allocation, with shivering providing rapid compensation until behavioral adaptations or longer-term physiological adjustments take effect. During intense shivering, energy expenditure can reach approximately 100-200 kcal per hour in humans, accounting for a substantial portion of total heat production and primarily fueled by in skeletal muscles, which supplies glucose for and aerobic . Muscle serves as the dominant source, supplemented by glucose and fatty acids, enabling sustained but potentially leading to if prolonged. Evolutionarily, shivering represents a conserved thermoregulatory across homeothermic animals, including mammals and , enabling survival in cold environments by preventing and supporting metabolic processes at optimal temperatures. This ancient likely predates the divergence of endothermic lineages, providing a reliable, muscle-based strategy for heat generation that complements more specialized traits like or .

Mechanisms

Neural Control

The neural control of shivering begins in the of the , which serves as the primary integrator of thermal signals for . Cold-sensitive neurons in this region detect decreases in core body temperature through inputs from peripheral thermoreceptors expressing transient receptor potential melastatin 8 () and ankyrin 1 () channels, which are activated by innocuous and noxious cold, respectively. These signals, relayed via the and lateral parabrachial nucleus, indicate that core temperature is below the hypothalamic set point of about 37°C, initiating shivering when core temperature falls approximately 0.5–1°C below this threshold, though this can vary by 1–2°C depending on individual variability and environmental factors. Warm-sensitive neurons in the medial tonically inhibit shivering pathways under normothermic conditions, but cold exposure disinhibits these circuits, activating downstream effectors for production. Shivering is executed through brainstem and spinal cord circuits that generate rhythmic motor patterns. The dorsomedial hypothalamus activates premotor neurons in the rostral raphe pallidus nucleus of the medullary raphe nuclei, which project via reticulospinal tracts to alpha motor neurons in the spinal cord's ventral horn. These connections produce oscillatory bursts of activity, synchronizing skeletal muscle contractions at frequencies of approximately 8–12 Hz to maximize heat generation without excessive fatigue. Gamma motor neurons, co-activated by these pathways, maintain muscle spindle sensitivity during the tremors, ensuring coordinated recruitment of motor units across antagonist muscle groups. This central pattern generation in the brainstem allows shivering to persist as an automatic reflex even under partial spinal anesthesia. Autonomic modulation by the enhances the intensity and efficiency of shivering. Activation of sympathetic preganglionic neurons in the intermediolateral cell column, driven by hypothalamic inputs, releases norepinephrine onto beta-adrenergic receptors in , potentiating contractility. Sympathetic activation, through co-transmitters like ATP, can enhance shivering intensity and , increasing and metabolic rate in muscles. Proprioceptive feedback mechanisms prevent overstimulation and during prolonged shivering. Muscle spindles, via Ia afferent fibers, detect length changes and provide excitatory input to alpha motor neurons through the arc, while Golgi tendon organs sense excessive tension and trigger inhibitory Ib afferents to suppress motor output via in the . This loop modulates shiver amplitude and frequency, protecting against muscle damage and allowing sustained for hours in cold exposure.

Muscular and Metabolic Processes

Shivering involves the recruitment of fibers, primarily fast-twitch type II fibers, which undergo asynchronous contractions to generate without producing significant mechanical work. These contractions predominantly occur in large muscle groups around the and proximal limbs, such as the and muscles, while sparing fine motor areas like the hands and face to maintain essential functions. The metabolic basis of shivering centers on the of (ATP) through the myosin-ATPase cycle during cross-bridge cycling in muscle fibers. This process couples ATP breakdown to actin-myosin interactions, where only about 20-25% of the is converted to mechanical work in typical contractions, with the remainder dissipated as ; in shivering, since no external work is performed, nearly all from ATP contributes to thermal output. Heat production during shivering can be quantified using the basic equation for : Q = m \cdot c \cdot \Delta T where Q is the generated, m is the of the or affected tissues, c is the of the (approximately 3.0 kJ/kg·°C for humans, based on recent estimates), and \Delta T is the change in . Through sustained shivering, this mechanism can raise core by approximately 0.5–1 °C per hour under moderate exposure, helping to counteract . Shivering is limited in duration by fatigue mechanisms, including the buildup of in fast-glycolytic fibers due to anaerobic metabolism, which leads to and impaired contractility, as well as calcium dysregulation from prolonged sarcoplasmic reticulum activity. These factors typically restrict maximal intense shivering to 1–2 hours before exhaustion sets in, after which declines.

Causes

Thermal Triggers

Shivering is primarily triggered by a drop in either core body temperature or mean skin temperature, with the latter contributing approximately 20% to the control of the response in unanesthetized humans. The core temperature threshold for shivering onset typically occurs around 35.5–36.5°C, while significant peripheral cooling can independently initiate the thermogenic response by activating cold-sensitive afferents in the skin. Environmental factors like exacerbate this by enhancing convective heat loss from the skin, thereby accelerating the rate of temperature decline and hastening shivering onset compared to still air conditions. In the context of hypothermia, shivering intensity varies with the stage of core temperature reduction. During mild (core temperature 32–35°C), shivering is most vigorous, serving as the primary mechanism to generate metabolic heat and counteract further cooling. As core temperature falls below 30–32°C in moderate to severe stages, shivering ceases due to neuromuscular exhaustion and impaired muscle function, leaving the body reliant on residual non-shivering or external warming. High-altitude environments impair shivering efficiency through , which suppresses the metabolic intensity of the response and reduces overall production. Reduced oxygen availability limits aerobic capacity in skeletal muscles, diminishing the effectiveness of shivering despite cold . Similarly, immersion in cold water dramatically accelerates loss via conduction and , removing from the up to 25 times faster than to air at the same temperature, thereby triggering shivering more rapidly and intensely. Among mammals, shivering efficiency is influenced by body size and the surface area-to-volume (SA/V) ratio, with larger species like humans exhibiting lower relative heat loss but reduced shivering efficacy compared to smaller mammals. Smaller mammals, possessing a higher SA/V ratio, experience greater passive heat dissipation and thus rely on more intense, proportionally higher metabolic rates during shivering to maintain euthermy. In contrast, humans' larger body mass results in a lower SA/V ratio, which conserves but limits the of shivering-generated warmth relative to total body volume.

Non-Thermal Triggers

Shivering can be triggered by emotional states such as or anxiety, where surges in adrenaline (epinephrine) activate the , leading to physiological responses that mimic the thermoregulatory shivering pathway. This activation involves the and nuclei, resulting in involuntary muscle contractions often described as "" or shakiness. For example, intense excitement, such as from listening to , can evoke similar frisson responses with shivers down the spine due to reward-related neural activity in brain regions like the . Shivering frequently occurs during fever, where endogenous or exogenous pyrogens such as interleukin-1 and act on the to raise the body's temperature set point. This results in thermoregulatory shivering () to generate heat and achieve the elevated set point, commonly associated with infections including viral, bacterial, or parasitic. Metabolic disturbances unrelated to ambient temperature can also induce shivering by altering the body's thermoregulatory set point. In , blood glucose levels below 3.5 mmol/L trigger counter-regulatory hormone release, including epinephrine and , which stimulate shivering as part of the autonomic response to restore energy balance. Similarly, thyroid storm—a life-threatening hyperthyroid —disrupts metabolic , lowering the effective thermoregulatory set point and provoking tremors and shivering alongside symptoms like fever and . Pharmacological factors, including and certain medications, represent another category of non-thermal triggers for shivering. Withdrawal from , such as during abrupt cessation after chronic use, elicits a noradrenergic surge in the , manifesting as flu-like symptoms including chills and shivering, often peaking within 24-48 hours. withdrawal, as seen with amphetamines or , can similarly involve autonomic instability leading to shakiness, though less prominently than in opioid cases. Additionally, , an agent, frequently causes infusion-related rigors (intense shivering) in up to 70% of patients, attributed to release and synthesis rather than pyrogenesis.

Clinical Significance

In Hypothermia and Cold Exposure

Shivering serves as the body's primary thermogenic response during mild , typically induced by prolonged cold exposure, where core drops to 32–35°C (89.6–95°F). This involuntary muscle activity generates heat through rapid contractions, helping to maintain vital organ function, but it demands significant metabolic energy, often leading to depletion and if the cold stress persists. As advances, the initial vigorous shivering may intensify before exhausting the body's reserves, marking a critical transition to more severe stages where protective mechanisms fail. In severe hypothermia, below approximately 30°C (86°F), shivering typically ceases due to neuromuscular impairment, ushering in a phase of paradoxical undressing. This phenomenon, observed in about 25% of hypothermia fatalities, involves and a paradoxical sensation of warmth, prompting victims to remove clothing and accelerate heat loss through behaviors like stripping or burrowing into snow. Such actions exacerbate core cooling, often resulting from hypothalamic dysfunction and impaired judgment, and have been documented in forensic analyses of cold-related deaths. During rewarming efforts, the phenomenon can occur, characterized by a continued decline in despite external heating. This results from peripheral , which mobilizes cold blood from the to the central circulation, potentially dropping by 0.5–1°C and risking arrhythmias if not monitored. Experimental studies in mild confirm this convective cooling effect, emphasizing the need for controlled rewarming to mitigate cardiac strain. Shivering exhaustion in untreated mild contributes to and , accelerating progression to moderate or severe stages with potentially fatal outcomes. While mild cases are generally survivable with , untreated progression elevates mortality risks, with overall accidental hypothermia fatality rates reported around 10–50% depending on comorbidities and duration. In vulnerable populations, this exhaustion phase heightens the likelihood of or . Occupational cold exposure significantly amplifies hypothermia risks among outdoor workers, particularly in regions during the 2020s. A 2023–2024 survey of workers found that 33% often or always felt at work, with median daily below 10°C exceeding two hours for many roles like power grid maintenance, correlating to elevated shivering episodes and potential. Such statistics underscore a 75% of intermittent discomfort across sectors, heightening annual incident rates in environments compared to temperate zones.

In Fever and Infections

Shivering plays a central role in the febrile response during infections and inflammatory conditions, where it serves as a mechanism to elevate body temperature to a newly reset hypothalamic thermoregulatory set point. Exogenous pyrogens, such as bacterial endotoxins, trigger the release of endogenous pyrogens including interleukin-1 (IL-1), which act on the hypothalamus to increase the set point, creating a sensation of cold despite normal or elevated core temperature. This mismatch prompts the activation of heat-generating responses, including shivering, to rapidly raise body temperature until equilibrium is reached at the higher set point. Cytokines such as tumor necrosis factor-alpha (TNF-α) and (PGE2) further mediate and amplify the neural signals driving shivering during immune activation. TNF-α, released by macrophages in response to , enhances the production of PGE2 in the via cyclooxygenase-2 pathways, intensifying the pyrogenic signal and promoting sustained shivering to support the febrile state. This cytokine-mediated amplification is particularly pronounced in systemic , where it coordinates the thermoregulatory response to combat proliferation. In certain infections, shivering manifests as rigors—intense, coordinated episodes of muscle contractions that generate significant heat, typically lasting 15-30 minutes. Rigors are hallmark features in conditions like , where cyclical release of parasites induces paroxysmal shivering followed by high fever, and in , where they signal rapid bacterial dissemination and . These episodes underscore shivering's role in the acute phase of , distinguishing it from milder thermogenic responses. Clinically, persistent shivering or rigors hold diagnostic value, often indicating a rising fever above 38.5°C and the need for early detection of underlying infections such as bacteremia. Their presence prompts targeted investigations like blood cultures, as they correlate with systemic inflammatory responses and higher risks of severe outcomes in febrile illnesses.

In Neurological and Other Disorders

In , dysfunction due to depletion often manifests as that can be mistaken for shivering, particularly in the where the rhythmic movements resemble slower shivering despite not being a true thermoregulatory response. These tremors affect approximately 70-80% of patients at some point in the disease course, with the enhanced oscillatory activity in basal ganglia-thalamo-cortical circuits contributing to the misperception. Distinguishing this from physiological shivering is crucial, as the typically diminishes with voluntary movement or action, unlike cold-induced shivering. Multiple sclerosis involves demyelination that disrupts neural conduction in thermoregulatory pathways, leading to episodic, involuntary muscle contractions that mimic shivering bursts, independent of core body . This dysfunction lowers the shivering to around 31.8°C. Such symptoms arise from lesions in the or , exacerbating and motor impairment during flares. Hyperthyroidism elevates basal metabolic rate through excess thyroid hormone (T3 and T4) production, which sensitizes beta-adrenergic receptors and increases catecholamine effects, often resulting in fine tremors that may be perceived as inappropriate shivering. These tremors, typically affecting the hands, face, or , stem from heightened sympathetic activity rather than exposure, occurring in up to 90% of untreated cases and resolving with beta-blockers or antithyroid . The metabolic acceleration disrupts normal , occasionally leading to subjective sensations of chilliness or shakiness despite overall . Drug-induced shivering frequently arises from alterations in pathways, as seen with neuroleptics (antipsychotics) that block D2 receptors, provoking including tremors resembling shivering in 20-30% of patients on typical agents. , used in , similarly disrupts dopamine balance and can induce shivering, particularly in toxicity states (serum levels >1.5 mmol/L), where it combines with effects to cause muscle rigidity and chills in moderate to severe cases. These reactions, often dose-dependent, require and dose adjustment to mitigate basal ganglia-like dysfunction without compromising therapeutic efficacy.

Variations in Populations

In the Elderly

In older adults over 65 years, the shivering response is blunted, with attenuated primarily due to , the age-related loss of mass and function. This reduction impairs the ability to generate heat effectively, as shivering typically boosts metabolic heat production by 300-500% in younger individuals, but this capacity is significantly diminished in the elderly. Additionally, aging leads to decreased hypothalamic sensitivity to temperature changes, further compromising central thermoregulatory control and resulting in a less intense and delayed shivering initiation. Comorbid conditions such as diabetes and cardiovascular disease exacerbate these impairments by further disrupting vasoconstriction and promoting excessive heat loss. In type 2 diabetes, attenuated cutaneous vasodilation delays heat dissipation responses, while reduced sympathetic vasoconstrictor tone hinders conservation of body heat during cold exposure. Similarly, heart failure is associated with excessive baseline vasoconstriction and impaired vasodilatory capacity, leading to shivering fatigue and accelerated core temperature decline in cold environments. These factors collectively heighten vulnerability to hypothermia, with studies indicating that older patients face a substantially elevated incidence compared to younger adults, often linked to shivering cessation and rapid physiological deterioration. Postmenopausal women exhibit more pronounced alterations in shivering responses due to estrogen deficiency, which disrupts hypothalamic thermoregulatory set points. loss narrows the —the range between heat loss and shivering thresholds—resulting in a higher mean body at which shivering begins and increased . This effect is particularly evident in women experiencing hot flashes, where the altered thresholds contribute to inefficient cold defense mechanisms and greater overall thermoregulatory inefficiency.

In Neonates and Children

Neonates exhibit immature , characterized by a limited capacity for shivering compared to adults, as their primary response to cold stress relies on non-shivering mechanisms rather than effective muscle-based heat production. This immaturity stems from underdeveloped neuromuscular systems, due to an immature neuromuscular system that prevents effective shivering. Neonates' limited stores in and liver increase the risk of and metabolic exhaustion during prolonged cold exposure. Prolonged cold exposure thus exacerbates energy depletion, increasing risks of and metabolic exhaustion in the early postnatal period. In neonates, (BAT) predominates as the key site for non-shivering , mediated by (UCP1) in mitochondrial membranes, which dissipates the proton gradient to generate heat without ATP synthesis. This BAT-driven process, activated by sympathetic stimulation and norepinephrine, supplements or largely replaces shivering during the first months of life, when muscle mass and efficiency remain low. BAT depots, rich in UCP1 expression from late gestation and peaking around birth, can increase metabolic heat production up to approximately twice the basal rate through non-shivering , ensuring survival in cool environments before shivering matures. Premature infants born before 37 weeks face heightened vulnerabilities, with significantly reduced capacity—often 50% or less than neonates—due to scant (1-2% of body weight versus 4% in infants) and immature enzyme systems for oxidation. Additionally, (SIDS) has been linked to impaired during sleep, where failures in responses may disrupt coordinated conservation and , particularly in prone positioning or overheating scenarios. Developmental maturation occurs progressively, with shivering patterns becoming more adult-like by around 1 year of age, as activity wanes and reliance shifts to voluntary muscle contractions supported by higher basal metabolic rates (1.5-2 times adult levels per ). This transition enables sustained during cold exposure, reflecting gains in muscle mass, neural control, and reserves that enhance endurance beyond the fragile neonatal phase.

Management

Prevention Strategies

Preventing shivering involves proactive measures to mitigate cold exposure and underlying health risks that trigger the response. In environmental contexts, wearing multiple layers of loose-fitting is a primary to enhance and retain , thereby reducing the likelihood of core drops that induce shivering. Organizations such as the (OSHA) recommend at least three layers: an inner moisture-wicking layer, a middle insulating layer like or synthetic , and an outer wind- and water-resistant shell. Maintaining is equally critical, as can impair and exacerbate cold stress; consuming warm, non-caffeinated fluids at regular intervals helps sustain plasma volume and core stability during exposure. Behavioral adaptations further bolster prevention, particularly for individuals like athletes or outdoor workers frequently in conditions. Cold acclimatization training, involving gradual exposure to low temperatures over several days to weeks, enhances metabolic efficiency and reduces the intensity of shivering by improving non-shivering and vascular responses. Avoiding consumption is essential, as it causes that impairs peripheral —a key heat-conserving —and reduces shivering metabolic by approximately 13%, increasing the risk of during cold exposure. Vaccinations and hygiene practices target non-thermal triggers like infections that cause febrile shivering. Annual vaccination is recommended by the Centers for Disease Control and Prevention (CDC) to prevent flu-related fever and associated chills, with effectiveness estimates of 40-60% in reducing confirmed influenza cases among adults and children in well-matched seasons. Good , such as frequent handwashing and avoiding close contact with ill individuals, complements vaccination by lowering overall rates, including those from respiratory viruses that provoke shivering through fever. Nutritionally, ensuring adequate intake supports reserves to avert or delay shivering onset in settings. In environments, individuals may require an additional 500-1,000 kcal per day beyond basal needs to replenish stores depleted by thermogenic demands, with often augmented by 1,000 kcal modules for Arctic operations to maintain metabolic heat production. Prioritizing carbohydrate-rich foods (e.g., 50-60% of intake) helps sustain muscle , as depletion impairs shivering efficiency and accelerates core cooling.

Treatment Interventions

Treatment of active shivering primarily focuses on addressing the underlying cause, such as , while employing supportive and pharmacological methods to suppress the response and prevent complications. Passive rewarming is the initial approach for mild cases, involving the removal of wet clothing and application of insulating layers like dry blankets to minimize loss, which can raise core body at a rate of 0.5 to 2 °C per hour without the need for medications. This method promotes endogenous production through preserved shivering until the core stabilizes above the shivering threshold, typically around 32–35 °C, thereby suppressing shivers naturally as recovers. Administration of warm intravenous fluids may complement passive external techniques in hypothermic patients, further supporting gradual rewarming while avoiding rapid shifts that could exacerbate instability. Pharmacological interventions are indicated when shivering persists despite passive measures or in moderate to severe hypothermia, with meperidine serving as a first-line agent due to its potent antishivering effects. Meperidine, an agonist at both μ- and κ-opioid receptors, reduces the shivering threshold by acting on thermoregulatory pathways in the , often at doses of 25–50 mg intravenously. This treatment achieves shivering resolution in approximately 80–90% of cases with a single dose, minimizing metabolic demands and oxygen consumption associated with intense shivering. Other opioids like are less effective at equivalent doses, highlighting meperidine's unique κ-receptor mediated action in suppressing the response. For severe shivering unresponsive to passive or pharmacological methods, active external rewarming using warming devices, such as convective blankets, is employed to deliver controlled external directly to , achieving rewarming rates of 0.5–4 °C per hour. These devices are preferred over techniques, which can provoke —a further decline in core temperature due to redistribution of cold peripheral blood upon rapid —and increase risks of cardiac instability. is thus avoided in favor of surface methods to ensure safer progression. Throughout , continuous is essential to guide interventions and detect complications from shivering. Core should be assessed using reliable probes, such as esophageal or rectal thermometers, to track rewarming progress and confirm suppression of the shivering . (ECG) is critical for identifying arrhythmias, as intense shivering can produce artifacts mimicking or other rhythms, while also elevating myocardial oxygen demand that may precipitate ventricular irregularities in hypothermic states.

References

  1. [1]
    Physiology, Thermal Regulation - StatPearls - NCBI Bookshelf
    Shivering is normally inhibited by signals from the heat center in the anterior hypothalamic-preoptic area but is excited by cold signals from the spinal cord ...
  2. [2]
    Central efferent pathways for cold-defensive and febrile shivering
    Shivering is an involuntary somatic motor response that occurs in skeletal muscles to produce heat during exposure to cold environments or during the ...Missing: treatment | Show results with:treatment
  3. [3]
    Chills: Causes & Treatment - Cleveland Clinic
    Feb 11, 2021 · Chills are your body's way of raising its core temperature. Cold temperatures, viruses, infections and other illnesses can bring on chills.
  4. [4]
    Hypothermia - Symptoms and causes - Mayo Clinic
    Apr 16, 2024 · Shivering is the body's attempt to warm itself. It is an automatic defense against cold temperature. Symptoms of hypothermia include: Shivering.Causes · Risk Factors · Prevention<|control11|><|separator|>
  5. [5]
    Chills: MedlinePlus Medical Encyclopedia
    Jan 1, 2025 · Chills are caused by rapid muscle contraction and relaxation. They are the body's way of producing heat when it feels cold. Chills often predict ...
  6. [6]
    Shivering: Causes, Treatment, When to Seek Help, and More
    A shiver is caused by your muscles tightening and relaxing in rapid succession. This involuntary muscle movement is your body's natural response to getting ...
  7. [7]
    Human studies concerning thermal-induced shivering, postoperative ...
    In addition, there was a frequency of 8 to 10 Hz associated with each low-frequency amplitude modulation. EMG signals from postoperative patients revealed ...
  8. [8]
    Tremor: Sorting Through the Differential Diagnosis - AAFP
    Feb 1, 2018 · A kinetic tremor is associated with voluntary movement and includes intention tremor, which is produced with target-directed movement. TABLE 1.
  9. [9]
    Types of Seizures | Johns Hopkins Medicine
    A seizure is a burst of uncontrolled signals between brain cells. This burst of electrical activity can causes stiffness, twitching, changes in behavior, ...
  10. [10]
    History of accidental hypothermia - PMC - NIH
    An example was a man of 45, described in 1859, who went out in a snow storm and when he returned, was shivering, cold and confused, with a poor attention span ...
  11. [11]
    Fever, Chills, and Night Sweats - Clinical Methods - NCBI Bookshelf
    Although suggestive of tuberculosis or lymphoma, they also occur in brucellosis, lung abscess, bacterial endocarditis, diabetic autonomic neuropathy, nocturnal ...Missing: besides | Show results with:besides
  12. [12]
    Shivering thermogenesis in humans: Origin, contribution and ...
    Thermogenic rates are characterized as mild (1–2 xRMR), moderate (2–3 xRMR) and high (>3 xRMR). Points represent data from end of cold exposure for following ...Missing: frequency | Show results with:frequency
  13. [13]
    Regulation of body temperature by the nervous system - PMC
    Four physiologic effectors are particularly important for thermoregulation in mammals: BAT thermogenesis, control of skin blood flow, shivering, and ...<|control11|><|separator|>
  14. [14]
    Biochemistry, Heat and Calories - StatPearls - NCBI Bookshelf - NIH
    It can increase the basal metabolic rate by as much as 5 to 6 times. The intensity of shivering depends on the core temperature and a person's BMI.
  15. [15]
    Cold-induced thermogenesis in humans - PMC - PubMed Central
    Nov 23, 2016 · However, when intense shivering occurred, the metabolism increased to ~ 400% of the BMR.
  16. [16]
    Physiology, Temperature Regulation - StatPearls - NCBI Bookshelf
    Jul 30, 2023 · Activating the primary motor center in the posterior hypothalamus causes skeletal muscle contraction and shivering, leading to increased heat ...Related Testing · Pathophysiology · Clinical Significance
  17. [17]
    Central neural control of thermoregulation and brown adipose tissue
    Hypothalamic regulation of shivering thermogenesis. Shivering thermogenesis is the last cold-defense mechanism to be activated as its thermal threshold is at ...
  18. [18]
    [PDF] cellular-bioenergetics-as-a-target-for-obesity-therapy.pdf - Tseng Lab
    Up to 250 kcal per hour are consumed by shivering 113, but this response is highly variable, usually of short duration, and not a likely method for ...
  19. [19]
    Chapter: 7 The Physiology of Cold Exposure
    Shivering, physical activity, or both increase heat production. Thus, heat balance in the cold and the requirement for shivering are dependent on the severity ...Human Heat Balance In The... · Physiological Responses · Energy Substrate Utilization<|separator|>
  20. [20]
    The role of skeletal-muscle-based thermogenic mechanisms in ...
    These studies suggest that during cold exposure both shivering and non-shivering thermogenic mechanisms are activated in mammals and birds (Chaffee & Roberts, ...
  21. [21]
    Muscle Non-shivering Thermogenesis and Its Role in the Evolution ...
    Muscle NST could have been the earliest mechanism of heat generation during cold exposure in vertebrates that ultimately enabled the evolution of endothermy.
  22. [22]
    TRP ion channels in thermosensation, thermoregulation and ...
    Among all the areas involved in thermoregulation, the preoptic area/anterior hypothalamus (POA/AH) is believed to be a key site for maintaining temperature ...
  23. [23]
    Central neural pathways for thermoregulation - PMC
    Central neural pathways for thermoregulation. Shaun F Morrison. Shaun F Morrison. 1Division of Neuroscience, Oregon National Primate Research Center, Oregon ...
  24. [24]
  25. [25]
  26. [26]
    Effect of the sympathetic nervous system co-transmitters ATP and ...
    Feb 27, 2015 · The existence of co-transmitters of the sympathetic nervous system norepinephrine (NE) and ATP implies variations in the neuromodulator ...
  27. [27]
    β‐Adrenergic modulation of skeletal muscle contraction: key role of ...
    Sep 24, 2015 · Our aim is to describe the acute effects of catecholamines/β-adrenergic agonists on contraction of non-fatigued skeletal muscle in animals and humans.
  28. [28]
    Golgi Tendon Organ - Physiopedia
    If there is too much muscle tension the golgi tendon organ will inhibit the muscle from creating any force (via a reflex arc), thus protecting the you from ...Missing: shivering | Show results with:shivering
  29. [29]
    Skeletal Muscle Thermogenesis and Its Role in Whole Body Energy ...
    Oct 24, 2017 · High intensity shivering activates large muscles and increases glycolysis as the main source for heat production. Since no work is done during ...
  30. [30]
    Skeletal Muscle Thermogenesis and Its Role in Whole Body Energy ...
    Oct 24, 2017 · During shivering, heat is primarily produced by the major ATP-utilizing enzymes, notably, myosin ATPase and SERCA.
  31. [31]
    Relative contribution of skin and core temperatures to ... - PubMed
    Skin temperature contributes approximately 20% to control of vasoconstriction and shivering in unanesthetized humans.
  32. [32]
    Increasing mean skin temperature linearly reduces the core ...
    Increasing mean skin temperature linearly reduces the core-temperature thresholds for vasoconstriction and shivering in humans · Authors · Affiliation.
  33. [33]
    Wind Chill | National Oceanic and Atmospheric Administration
    The wind chill is the effect of the cold wind on people and animals – as the wind increases, it removes heat from the body faster, driving down skin temperature ...
  34. [34]
    Hypothermia - StatPearls - NCBI Bookshelf
    Jan 19, 2024 · Shivering allows the body to produce up to a 5-fold heat increase from baseline spontaneously. However, this method requires adequate glucose ...
  35. [35]
    Hypoxia-induced changes in shivering and body temperature
    Exposure to various levels of hypoxia produced graded suppression of shivering, with the result that the change in body temperature varied directly with ...
  36. [36]
    You're not a polar bear: The plunge into cold water comes with risks
    Dec 9, 2022 · Being immersed in cold water triggers hypothermia faster than just being out in the cold, because water takes heat away from the body 25 times ...
  37. [37]
    Size and Power in Mammals | Journal of Experimental Biology
    Oct 1, 1991 · INTRODUCTION. The relationship between body size and energy metabolism in animals has been studied for more than 150 years.
  38. [38]
    Endothermy | CK-12 Foundation
    Nov 1, 2025 · Mammals can also generate little bursts of heat by shivering. ... Big animals have a lower surface area to volume ratio. That means ...
  39. [39]
    Music-Evoked Emotions—Current Studies - PMC - PubMed Central
    Nov 24, 2017 · ... chills” or “shivers down the spine.” Increased chill intensity was observed in brain regions ascribed to reward and emotion such as the ...
  40. [40]
    Incidence of the “Adrenaline Rush” and Vasovagal Response with ...
    Jun 24, 2021 · Eight (2.2%) of the patients had adrenaline rush symptoms, which included nervousness, anxiety, tremors, shaky feelings, flushing ...
  41. [41]
    Learn More – Hyperglycemia and hypoglycemia in type 2 diabetes
    Dec 18, 2023 · What are the signs of hypoglycemia? · Racing pulse · Cold sweats · Pale face · Headache · Feeling very hungry · Shivering, feeling weak in the knees.
  42. [42]
    Thyroid Storm - Endotext - NCBI Bookshelf - NIH
    Apr 15, 2025 · Classic features of thyroid storm include fever, marked tachycardia, heart failure, tremors, nausea and vomiting, diarrhea, dehydration ...Missing: shaking shivering
  43. [43]
    Clinical Guidelines for Withdrawal Management and Treatment of ...
    Opioids are drugs such as heroin, opium, morphine, codeine and methadone. Opioid withdrawal can be very uncomfortable and difficult for the patient. It can feel ...
  44. [44]
    Amphotericin B-induced shivering in patients with cancer - PubMed
    Shivering is a common and distressful reaction associated with administration of amphotericin B, a systemic antifungal agent. Shivering occurs as a result ...
  45. [45]
    Essential tremor - Symptoms and causes - Mayo Clinic
    Mar 15, 2025 · Essential tremor is a nervous system condition, also known as a neurological condition. It causes rhythmic shaking that you can't control.Diagnosis and treatment · Essential tremor test · Deep brain stimulation
  46. [46]
    "Terminal burrowing behaviour"--a phenomenon of lethal hypothermia
    In our material this paradoxical undressing occurred in 25% of the cases and nearly all exhibited an additional phenomenon which has not yet been described in ...
  47. [47]
    Paradoxical Undressing and Hypothermia - Semantic Scholar
    This paper presents a study of the association between hypothermia and paradoxical undressing. Seventy per cent of the cases showed this feature in a series ...
  48. [48]
    Afterdrop of body temperature during rewarming - PubMed
    Afterdrop, the continued fall of deep body temperatures during rewarming after hypothermia, is thought to endanger the heart by further cooling from cold blood.
  49. [49]
    Hypothermia Evidence, Afterdrop, and Practical Experience
    Careful physiology experiments involving mild hypothermia using active rewarming have consistently demonstrated an afterdrop of approximately 0.5°C in controls ...
  50. [50]
    Cold exposure among outdoor workers in the Arctic setting - PMC
    Sep 23, 2025 · In the survey, 33% of workers indicated that they often or always felt cold at work, and 39% reported that they had inadequate knowledge about ...
  51. [51]
    Physiology, Fever - StatPearls - NCBI Bookshelf
    Sep 4, 2023 · In fever, there is an increase in the 'set-point' temperature brought about by the hypothalamus, enabling the body to maintain a controlled ...
  52. [52]
    Fever - Infectious Diseases - Merck Manual Professional Edition
    Jul 22, 2019 · Fever results when something raises the hypothalamic set point, triggering vasoconstriction and shunting of blood from the periphery to ...
  53. [53]
    Understanding the pathophysiology of fever - Lippincott
    In response to the sudden increase in set point, the hypothalamus initiates heat production behaviors (shivering and vasoconstriction) that raise the core body ...
  54. [54]
    Neural Mechanisms of Inflammation-Induced Fever - PMC
    Fever is a common symptom of infectious and inflammatory disease. It is well-established that prostaglandin E2 is the final mediator of fever, which by binding ...
  55. [55]
    Circulating Cytokines as Mediators of Fever - Oxford Academic
    Induction of fever is mediated by the release of pyrogenic cytokines such as tumor necrosis factor (TNF), interleukin (IL)-1, IL-6, and interferons into the ...Missing: shivering | Show results with:shivering
  56. [56]
    Fever and the thermal regulation of immunity - PubMed Central - NIH
    These innate immune cells release prostaglandin E2 (PGE2) as well as pyrogenic cytokines (namely, interleukin-1 (IL-1) IL-6, and tumour necrosis factor (TNF)) ...
  57. [57]
    Rigors | Doctor - Patient.info
    A rigor is an episode of shaking or pronounced shivering which can occur with a high fever. It is an extreme reflex response which occurs for a variety of ...
  58. [58]
  59. [59]
    Approach to new fever or rigors - EMCrit Project
    Oct 22, 2025 · Rigors are shaking chills, which can be very dramatic. They represent an aggressive attempt by the hypothalamus to rapidly increase body ...
  60. [60]
    Utility of shaking chills as a diagnostic sign for bacteremia in adults
    Jun 11, 2024 · Shaking chills are a highly specific but less sensitive predictor of bacteremia. Blood cultures and early initiation of antibiotics should be considered for ...
  61. [61]
    Tremor in Parkinson's
    The tremor of Parkinson's disease is often confused with the tremor of a condition called Essential Tremor, or Benign Familial Tremor. Katherine Hepburn had ...Types Of Tremor · Foot Tremors · Prognosis & Treatment
  62. [62]
    Tremor in Parkinson's Disease: From Pathophysiology to Advanced ...
    Sep 13, 2022 · Tremor is one of the most common motor symptoms in PD and is reported to affect up to 75% of patients during their disease course.
  63. [63]
    Multiple sclerosis and thermoregulatory dysfunction
    Multiple sclerosis and thermoregulatory dysfunction. David G. Baker. David ... shivering. It was found that the sweating threshold was a full 1°C higher ...Multiple Sclerosis And... · Cranial Radiator · Exercise-Induced Heat<|separator|>
  64. [64]
    Temperature sensitivity in multiple sclerosis: An overview of its ...
    The primary driver of cold sensitivity in MS seems to be associated with the presence of demyelinating lesions within the hypothalamus (i.e. the main CNS area ...
  65. [65]
    Physiology, Thyroid Hormone - StatPearls - NCBI Bookshelf
    Jun 5, 2023 · Thyroid hormone increases the basal metabolic rate. It increases the gene expression of Na+/K+ ATPase in different tissues leading to increased ...Missing: shivering | Show results with:shivering
  66. [66]
    Extrapyramidal Side Effects - StatPearls - NCBI Bookshelf
    Extrapyramidal side effects, also referred to as medication-induced movement disorders, are common adverse drug reactions caused by antipsychotic medications.Missing: shivering | Show results with:shivering
  67. [67]
    Lithium Toxicity: What It Is, Causes, Symptoms & Treatment
    Aug 21, 2023 · Sweating and shivering. Confusion, disorientation or delirium. Rapid ... This causes your kidneys to reabsorb lithium, which increases the ...
  68. [68]
    Cold temperatures, hot risks: perioperative hypothermia in geriatric ...
    Sarcopenia diminishes shivering thermogenesis and impairs passive heat distribution and insulation due to the reduced vascularity of skeletal muscle, ...Missing: insensitivity | Show results with:insensitivity
  69. [69]
    Sympathetic regulation during thermal stress in human aging and ...
    This review article highlights the sympathetic responses of humans to thermal stress, with a specific focus on primary aging as well as impairments that occur ...
  70. [70]
    Incidences of underlying causes of hypothermia in older patients in ...
    Research showed that older patients are more vulnerable to develop hypothermia [1]. Hypothermia is associated with a high risk of morbidity and mortality, and ...
  71. [71]
    Altered Shivering Threshold in Postmenopausal Women with...
    These data suggest that the thermoneutral zone between the threshold for shivering and that for heat loss is narrowed in postmenopausal women with hot flashes.
  72. [72]
    Thermoregulation: Advances in Preterm Infants - AAP Publications
    Dec 1, 2017 · They are unable to shiver in cold environments, though they show an increase in oxygen consumption as well as heat production. After birth, with ...
  73. [73]
    Physiology, Neonatal - StatPearls - NCBI Bookshelf
    Apr 24, 2023 · Glycogen storage occurs in late gestation but is not yet sufficient to help the neonate in times of prolonged fasting; therefore, supplemental ...Missing: thermoregulation thresholds
  74. [74]
    The Role of Brown Adipose Tissue and Energy Metabolism in ...
    Jul 1, 2023 · Neonates use diverse mechanisms to thermoregulate, such as shivering and non-shivering thermogenesis. These strategies can be more efficient in ...Missing: thresholds fatigue
  75. [75]
    Relevance of brown adipose tissue in infancy and adolescence
    Oct 22, 2012 · The adipose organ is a complex endocrine system, composed of white and brown fat. White adipose tissue (WAT) serves as the primary site of ...
  76. [76]
    UCP1: the only protein able to mediate adaptive non-shivering ...
    Mar 1, 2001 · Whereas the thermogenic effect of fatty acids in brown-fat cells is fully UCP1-dependent, this is not the case in brown-fat mitochondria; this ...
  77. [77]
    Thermal Stress in Sudden Infant Death: Is There an Ambiguity With ...
    Apr 1, 2001 · Thermal stress and moderate hyperthermia (fever) have been implicated in sudden infant death syndrome (SIDS) since 1980.
  78. [78]
    Energy Metabolism in Children and Adolescents - ResearchGate
    The rate of children's basal metabolism is 1.5-2 times higher, but the maximum activity level is considerably lower than that of an adult. This results in a ...
  79. [79]
    Pediatric Thermoregulation: Considerations in the Face of Global ...
    Children are smaller than adults, with associated smaller total body surface area (BSA), lower total muscle mass, and metabolic heat production during exercise ...
  80. [80]
  81. [81]
    Cold Environments - Control Measures - CCOHS
    Clothing should be worn in multiple layers which provide better protection than a single thick garment. The air between layers of clothing provides better ...
  82. [82]
    Influence of Cold Stress on Human Fluid Balance - NCBI - NIH
    Ingestion of glycerol in drinking water might be an effective countermeasure to reduce or delay cold-induced dehydration and the associated decrements to ...
  83. [83]
    Cold Acclimation and the Effect on Sport Performance - Physiopedia
    Exercise in the cold can have an effect on immune function, since shivering induced muscle contractions are similar to contractions during a bout of exercise.
  84. [84]
    Effect of alcohol on thermal balance of man in cold water - PubMed
    Alcohol reduced shivering metabolic rate by an overall mean of 13%, insufficient to affect cooling rate. Alcohol had no effect on metabolic rate during exercise ...<|separator|>
  85. [85]
    Preventing Seasonal Flu | Influenza (Flu) - CDC
    Sep 26, 2025 · CDC recommends a yearly flu vaccine as the first and most important action in reducing your risk of flu and its potentially serious outcomes.Missing: febrile shivering
  86. [86]
    Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness ...
    Vaccination is still the most effective way of preventing and controlling influenza morbidity and mortality and as a consequence the WHO recommends 75% vaccine ...
  87. [87]
    Nutritional Needs In Cold And In High-Altitude Environments - NCBI
    The standard T Ration is augmented with a cold-weather supplement module to provide 1,000 kcal per meal extra energy for cold environments. This Arctic T (T ...
  88. [88]
    Muscle Metabolism and Shivering During Cold Stress - NCBI - NIH
    As one might presume, the increase in metabolic rate during shivering is caused by increases in oxidation of both fat and carbohydrate, but the relative ...Missing: glycogenolysis source
  89. [89]
    Preventing shivering with adjuvant low dose intrathecal meperidine
    Nov 10, 2017 · Meperidine is the only opioid that is an agonist at both the μ and κ receptors closely related to the pathogenesis of shivering by reducing the ...
  90. [90]
    Meperidine compared to morphine for rigors associated with ...
    Meperidine, either at flat doses of 25 to 50 mg or weight based dosing of 0.4 mg/kg, has been shown to be effective at shivering resolution in 89% to 90% of ...
  91. [91]
    Meperidine decreases the shivering threshold twice as ... - PubMed
    Meperidine administration is a more effective treatment for shivering than equianalgesic doses of other opioids. However, it remains unknown whether ...
  92. [92]
    Accidental Hypothermia: 2021 Update - PMC - PubMed Central
    Increased afterdrop could cause rescue collapse. Active External Rewarming. Active rewarming including forced-air surface rewarming [94,95], heating pads ...
  93. [93]
    Accidental hypothermia–an update: The content of this review is ...
    Sep 15, 2016 · Prehospital insulation, rewarming, rescue collapse and afterdrop. Shivering and active movement are very efficient mechanisms of heat ...
  94. [94]
    Temperature Control after Cardiac Arrest - PMC - PubMed Central
    Many forced-air warming blankets are available but add up to 170W heat to the body that must be balanced by any device trying to remove heat from the body.
  95. [95]
    Changes in electrocardiogram parameters during acute ...
    Feb 13, 2021 · During hypothermia (core temperature <35°C), common ECG features are tremor artifact from shivering, initial increase in heart rate (HR) in ...
  96. [96]
    Hypothermia: Beyond the Narrative Review—The Point of View of ...
    Dec 5, 2023 · In mild hypothermia, the patient is conscious and presents vigorous shivering, increased cardiac output due to increased peripheral resistance, ...